跳至主要内容
临床试验/DRKS00018932
DRKS00018932已完成未知

Colon Cancer Prevention - Innovative Strategies at the NCT - DARIO

ationales Centrum für Tumorerkrankungen (NCT) und Deutsches Krebsforschungszentrum (DKFZ)0 个研究点目标入组 2,787 人开始时间: 2019年10月31日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
2,787

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Open (masking not used)

入排标准

年龄范围
50 Years 至 54 Years(—)
性别
All

入选标准

  • Women or men
  • - Age 50 (>49) to 54 (<55) at the day of invitation to the study
  • - Main residence in Heidelberg, Mannheim and Rhine-Neckar-Kreis (as defined by community codes)
  • - Ability to speak and understand German language
  • - Ability to give legally binding informed consent

排除标准

  • Participants, who have a history of colorectal cancer.
  • - have had a colonoscopy in the previous 5 years.
  • - have a history of FAP (Familial Adenomatous Polyposis) or Lynch Syndrome.
  • - are severely ill and not able to visit the IEZ

研究者

发起方
ationales Centrum für Tumorerkrankungen (NCT) und Deutsches Krebsforschungszentrum (DKFZ)

相似试验